Evidence map›Paper›PMID 41291606›Full record

Trial reportBMC public health2025

A hybrid type III effectiveness-implementation study designed to test implementation best practices of deploying a Screen-Triage-Treat approach to cervical cancer screening and management utilizing self-collected HPV DNA testing in Chokwe District, Mozambique.

Troy D Moon, Mila P Salcedo, Elzier Mavume-Mangunyane, Mohsin Sidat, Cesaltina Lorenzoni, Ellen Baker, Gustavo Amorim, Valerie A Paz-Soldán, Kathryn T Kampa, Kathleen Condon and 2 more

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06810739 (A Hybrid Type III Effectiveness - Implementation, Pragmatic Intervention Trial for Cervical Cancer Screen and Treat in Mozambique), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06810739 narecruitingnot on this mapstarted 2026, after this paper: background citation

A Hybrid Type III Effectiveness - Implementation, Pragmatic Intervention Trial for Cervical Cancer Screen and Treat in Mozambique

TypeinterventionalSponsorTulane UniversityRan2026 to 2028Enrolled8,445ConditionsHuman Papilloma Virus Related Cervical CarcinomaArmsHPV DNA testing be self-collected vaginal swab
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Troy D MoonDepartment of Tropical Medicine and Infectious Diseases, Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA. tmoon2@tulane.edu.ORCID 0000-0002-1637-829X
Mila P SalcedoDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Elzier Mavume-MangunyaneFaculty of Medicine, University Eduardo Mondlane, Maputo, Mozambique.
Mohsin SidatFaculty of Medicine, University Eduardo Mondlane, Maputo, Mozambique.
Cesaltina LorenzoniFaculty of Medicine, University Eduardo Mondlane, Maputo, Mozambique.
Ellen BakerDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gustavo AmorimDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Valerie A Paz-SoldánDepartment of Tropical Medicine and Infectious Diseases, Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA.
Kathryn T KampaDepartment of Tropical Medicine and Infectious Diseases, Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA.
Kathleen CondonDepartment of Tropical Medicine and Infectious Diseases, Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA.
Harriett MyersDepartment of Tropical Medicine and Infectious Diseases, Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA.
Jahit SacarlalFaculty of Medicine, University Eduardo Mondlane, Maputo, Mozambique.

Funding

A hybrid type III effectiveness-implementation, pragmatic intervention trial for cervical cancer screen and treat in MozambiqueU01CA294674 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI D. Troy Moon, Jahit Sacarlal · 2024 to 2026
$1.9M
NCI NIH HHS U01 CA294674NCI NIH HHS U01CA294674NCI NIH HHS U01CA294674, P30CA016672
6 · The paper itself

Abstract

backgroundThe current World Health Organization (WHO) recommendation for cervical cancer screening utilizing HPV DNA testing is now being endorsed by the Mozambican Ministry of Health (MOH). Initial studies showing the feasibility of screening in the Mozambican context have been encouraging, with women participants reporting a preference for self-collection approaches. A high HPV prevalence among women living with HIV/AIDS will result in a significantly higher number of women requiring follow up, many of whom can receive thermal ablation at the primary level to avoid creating bottlenecks for those who require specialized follow up. Studies designed to evaluate best practices for implementation among a high-risk, lower-resourced population within Mozambique´s already busy HIV care and treatment services are needed to provide the evidence required national scale-up this approach.

methodsThe overall aim of this study is to evaluate implementation best practices for deploying a Screen-Triage-Treat approach to cervical cancer screening and management utilizing self-collected HPV DNA testing among HIV-infected women in care within select health facilities of Chókwè District, Mozambique. The main objectives are 1) to develop an in-depth understanding of the HPV Screen-Triage-Treat care cascade within HIV care and treatment based on a collaborative, exploration-focused process with local stakeholders; 2) to evaluate the effectiveness of the Screen-Triage-Treat approach utilizing self-collected HPV DNA testing; and 3) to use the Consolidated Framework for Implementation Research (CFIR) to identify factors that explain site- and provider-level variation in the implementation of the Screen-Triage-Treat approach to cervical cancer screening and management. DISCUSSION: This study will contribute to the literature related to cervical cancer screening and management, and to implementation science by providing information on how screening and management can be implemented within the high-volume HIV care and treatment clinics of Mozambique. Studies that generate evidence on barriers and facilitators to the uptake of this approach, and that identify context-specific implementation strategies are important for large-scale adoption. The knowledge gained from this study will be used to assist decision makers in determining a course of action for increasing cervical cancer screening and management coverage, optimizing the intervention's impact, and translating our findings into evidence-based programming.

trial registrationNCT06810739 (Protocol ID: 2024-1641). Registered 04 February 2025, at https://clinicaltrials.gov/.

Indexed as

Early Detection of CancerPapillomavirus InfectionsTriageUterine Cervical NeoplasmsAdultFemaleHIV InfectionsHumansMass ScreeningMiddle AgedMozambiqueCervical cancerHIVHuman papilloma virusImplementation scienceMozambiqueProtocolSelf-collection

Identifiers

PMID41291606
PMCPMC12763959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.